Wave Life Sciences (0VS) Income Statement
Wave Life Sciences Income Statement
Last quarter (Q3 2026), Wave Life Sciences's total revenue was $13.16M, an increase of 72.95% from the same quarter last year. In Q3, Wave Life Sciences's net income was $-61.91M. See Wave Life Sciences’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 42.73M | $ 108.30M | $ 113.31M | $ 3.65M | $ 40.96M | |
| $ 33.88M | $ 108.30M | $ 113.31M | $ 3.65M | $ 40.96M | |
| $ 249.26M | $ 218.71M | $ 181.30M | $ 166.37M | $ 167.98M | |
| Depreciation and Amortization | $ 8.85M | $ 8.66M | $ 9.21M | $ 10.11M | $ 9.84M |
| $ -195.53M | $ -88.34M | $ -48.98M | $ -151.03M | $ -112.61M | |
| $ -215.38M | $ -110.40M | $ -68.00M | $ -162.72M | $ -127.02M | |
| $ 11.01M | $ 13.39M | $ 9.81M | $ 1.58M | $ 4.57M | |
| $ -204.38M | $ -97.01M | $ -58.19M | $ -161.14M | $ -122.45M | |
| $ -204.38M | $ -97.01M | $ -57.51M | $ -161.82M | $ -122.25M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.21 | $ -0.70 | $ -0.54 | $ -2.05 | $ -2.36 |
| Diluted EPS | $ -1.21 | $ -0.70 | $ -0.54 | $ -2.05 | $ -2.36 |
| Weighted Average Shares Outstanding | 168.65M | 138.28M | 106.10M | 78.86M | 51.83M |
| Weighted Average Shares Outstanding (Diluted) | 168.65M | 138.28M | 106.10M | 78.86M | 51.83M |
Currency in USD
